Solid Biosciences LLC (SLDB)
Healthcare
Biotechnology
8.00 $
-0.5%
vs. previous close
Closing price · As of: 3. Aug 2026
Solid Biosciences LLC (SLDB) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -47 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -27 | -18 | -21 | -25 | -21 | -24 | -30 | -32 | -37 | -33 | -54 | -47 | -172 | |
| 0.7 | 0.6 | 0.6 | 0.3 | 1.2 | 0.4 | 0.5 | 0.4 | -0.5 | 0.4 | 0.0 | -0.6 | -0.8 | |
| 1.9 | 1.6 | 1.9 | 1.6 | 2.1 | 3.0 | 3.8 | 3.3 | 3.1 | 3.9 | 6.5 | 5.2 | 19 | |
| 1.9 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -6.7 | 1.2 | -1.9 | -2.2 | 0.1 | 2.8 | 2.1 | 1.8 | -2.5 | 7.2 | -13 | 2.3 | -6.3 | |
| 0.5 | 0.4 | 0.1 | 0.1 | 0.3 | 0.0 | 0.2 | 0.1 | 0.4 | 0.1 | 0.6 | 0.2 | 1.2 | |
| -48 | -25 | 45 | -38 | -5.2 | -11 | 39 | -27 | -33 | -45 | 47 | 45 | 14 | |
| 0.1 | 0.1 | -0.2 | -4.8 | 4.8 | -5.1 | 0.0 | 0.0 | -1.7 | 0.0 | 0.0 | -13 | -15 | |
| – | – | – | – | – | -0.1 | -0.1 | -0.1 | -0.1 | -0.2 | -0.2 | 0.0 | -0.6 | |
| 2.6 | 2.6 | 0.5 | 107 | 5.0 | 3.3 | 6.9 | 190 | -1.6 | 1.2 | 5.1 | 239 | 244 | |
| -73 | -43 | 25 | 44 | -22 | -31 | 16 | 130 | -72 | -78 | -1.4 | 237 | 86 | |
| -28 | -18 | -21 | -25 | -22 | -24 | -30 | -32 | -38 | -34 | -54 | -47 | -173 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.